FSSAI sends notices to Nestle India and Zydus Wellness
In short
FSSAI has sent notices to Nestle India and Zydus Wellness over claims made for infant and child products. The reports say the regulator wants scientific proof for Lactogen Pro 1, Nan Excella Pro Stage 1 and Complan.
This matters because the companies may have to defend their product claims. The reports do not say whether any penalties have been decided yet.
What the reporting says
FSSAI issued notices to Nestle India and Zydus Wellness over claims on infant and child nutrition products, according to publisher summaries. The regulator sought scientific evidence for claims linked to Lactogen Pro 1, Nan Excella Pro Stage 1 and Complan, while one report said scrutiny also covered an Instagram promotion involving infant milk substitutes. The immediate consequence is regulatory review, but the final outcome is not stated.
Why it matters
FSSAI’s notices put Nestle India and Zydus Wellness under scrutiny for marketing claims tied to infant formula and child nutrition products. The regulator is reportedly asking for scientific evidence, and one summary says an Instagram promotion involving infant milk substitutes is also being reviewed. The reporting does not state any penalty, withdrawal, or final regulatory decision.